TheOphthoManual
Oculoplastics

Blepharoptosis

Last updated 2026-07-28 · Drafted from 4 cited sources

Overview

Blepharoptosis, commonly shortened to ptosis, is an abnormally low position of the upper eyelid margin relative to its normal resting position, which in primary gaze typically sits just below the superior corneal limbus. Ptosis can be congenital (present from birth or early infancy) or acquired later in life, and while many cases are benign and slowly progressive, ptosis can also be the presenting sign of serious neurologic or neuromuscular disease — making accurate categorization by underlying mechanism a clinical priority rather than a purely cosmetic concern.

Epidemiology & Risk Factors

Acquired ptosis becomes more common with age, most often from age-related stretching or dehiscence of the levator aponeurosis, and is frequently encountered incidentally in cosmetic and dermatologic practice due to its overlap with periocular aging changes.1 Ptosis can also arise iatrogenically — for example, after periocular procedures, botulinum neurotoxin administration in the periocular region, or as a complication of prior blepharoptosis or blepharoplasty surgery itself (overcorrection leading to upper eyelid retraction, or undercorrection leaving residual ptosis).14 Congenital ptosis, by contrast, most often results from a localized dystrophy of the levator palpebrae superioris muscle rather than a systemic or neurologic process, though it can occur with poor levator function requiring a different surgical approach than acquired disease.3

Pathophysiology

Ptosis results from dysfunction anywhere along the pathway responsible for elevating the upper eyelid: the levator palpebrae superioris muscle (innervated by cranial nerve III) and its aponeurosis, the sympathetically-innervated Müller's muscle, or the neuromuscular junction and upper motor neuron pathways controlling these muscles. The mechanism differs meaningfully by category: aponeurotic ptosis results from stretching, thinning, or dehiscence of the levator aponeurosis from its normal insertion (typically age-related or post-surgical/post-inflammatory, with generally preserved levator muscle function); myogenic ptosis results from primary muscle dysfunction (congenital dystrophy, myasthenia gravis, or other myopathies); neurogenic ptosis results from impaired innervation (CN III palsy, Horner syndrome affecting Müller's muscle); and mechanical ptosis results from a structural mass or weight on the eyelid (chalazion, eyelid tumor, severe dermatochalasis) that physically restricts elevation.

Clinical Presentation

Patients typically report a droopy eyelid noticed by themselves or others, superior visual field restriction (particularly affecting the upper field, and worsened by fatigue in some myogenic causes), or a compensatory chin-up head posture/frontalis overaction (brow elevation) used to lift the visual axis above the ptotic lid. Children with congenital ptosis may be identified by caregivers or on routine exam, sometimes with an associated compensatory head tilt or chin-up posture that can itself become a habitual postural change if uncorrected. Acquired ptosis that varies through the day, worsens with fatigue, or is accompanied by other muscle weakness should specifically raise concern for myasthenia gravis.

Exam Findings

  • Margin reflex distance 1 (MRD1): the distance from the corneal light reflex to the upper lid margin in primary gaze — the standard quantitative measure of ptosis severity, with a normal value of approximately 4-5 mm1
  • Levator function: measured as the excursion of the upper lid margin from downgaze to upgaze while the frontalis muscle is manually immobilized; poor levator function (typically defined as under roughly 4-5 mm) indicates more severe muscle dysfunction and influences surgical approach3
  • Standardized preprocedure and postprocedure photography to document baseline asymmetry and track treatment response1
  • Pupil size and reactivity — critical to assess in any new ptosis, since anisocoria with ptosis raises concern for Horner syndrome (miotic pupil) or CN III palsy (mydriatic, poorly reactive pupil, often with associated ophthalmoplegia)
  • Fatigability of ptosis with sustained upgaze, or improvement with an ice-pack test, supporting a diagnosis of myasthenia gravis2

Classification

  • Aponeurotic: stretching or dehiscence of the levator aponeurosis; most common cause of acquired ptosis, generally with good levator function
  • Myogenic: primary muscle or neuromuscular junction dysfunction — includes congenital levator dystrophy, myasthenia gravis, and other myopathies (e.g., chronic progressive external ophthalmoplegia)
  • Neurogenic: impaired innervation — CN III palsy (often with associated ophthalmoplegia and pupil involvement) or Horner syndrome (ptosis, miosis, and anhidrosis from sympathetic disruption, typically with only mild ptosis due to Müller's muscle rather than levator involvement)
  • Mechanical: a structural mass, lesion, or excess tissue weight (chalazion, tumor, severe dermatochalasis) physically restricting eyelid elevation
  • Traumatic/iatrogenic: direct injury to the levator or its aponeurosis, including as a complication of prior eyelid or periocular surgery

Differential Diagnosis

Because ptosis is a physical sign rather than a single diagnosis, the differential is really a differential of underlying cause, and should specifically consider:

  • Myasthenia gravis — the diagnostic workup extends beyond bedside fatigability testing to antibody testing (AChR, MuSK), electrophysiologic studies (repetitive nerve stimulation, single-fiber EMG), and chest imaging to screen for thymoma in all confirmed cases regardless of subtype2
  • Horner syndrome (ptosis, miosis, anhidrosis)
  • CN III palsy (ptosis with ophthalmoplegia ± pupil involvement — pupil involvement suggests a compressive, potentially aneurysmal lesion requiring urgent neuroimaging)
  • Congenital myasthenic syndromes and other cranial neuropathies, which are specifically noted as important differentials to distinguish from acquired myasthenia gravis2
  • Simple dermatochalasis (excess, redundant eyelid skin) mimicking true ptosis without true lid-margin malposition
  • Contralateral eyelid retraction making the unaffected side appear falsely elevated, creating the illusion of ptosis on the normal side

Management

Management depends entirely on the underlying mechanism and severity. Mild acquired ptosis, particularly aponeurotic ptosis, can be identified and managed with validated diagnostic metrics (MRD1, levator function) even outside of ophthalmology-specific settings, and appropriately triaged for surgical referral when indicated.1

Nonsurgical options for select cases of mild acquired ptosis include topical oxymetazoline 0.1%, which has shown modest but statistically significant improvement in MRD1 and superior visual field in randomized trials, and off-label adrenergic agents; targeted pretarsal botulinum toxin injection has also been described as an adjunctive option in selected cases, though the supporting evidence for this specific approach remains limited.1

Surgical repair is guided primarily by levator function. In patients with good levator function, aponeurotic repair or levator resection/advancement is typically favored. In severe congenital ptosis with poor levator function, frontalis muscle suspension or advancement techniques — using the forehead muscle to mechanically substitute for a poorly-functioning levator — remain a mainstay, though a review of the technique's evolution over decades found continued variability in surgical standardization across published series, indicating that no single approach has been definitively established as superior.3

Surgical overcorrection is a recognized complication requiring its own stepwise management: iatrogenic upper eyelid retraction following blepharoptosis overcorrection or improper blepharoplasty can be corrected with a graduated approach — releasing the pretarsal cicatrix or levator aponeurosis first, then recessing, and if needed lengthening, the levator-Müller's muscle complex — an approach shown in a retrospective series to achieve good or fair symmetry in the large majority of treated eyelids.4

Complications

  • Amblyopia in children with congenital ptosis severe enough to occlude the visual axis — a genuine urgency distinguishing pediatric from adult ptosis evaluation
  • Compensatory chin-up head posture becoming habitual if uncorrected in childhood
  • Exposure keratopathy from lagophthalmos after ptosis surgery, particularly overcorrection
  • Iatrogenic upper eyelid retraction from surgical overcorrection, itself requiring further corrective surgery4
  • Missed diagnosis of a serious underlying cause (myasthenia gravis, compressive CN III lesion) when ptosis is treated purely as a cosmetic finding

Clinical Pearls

  • MRD1 and levator function are the two measurements that most directly guide both diagnosis and surgical planning — always document both, not acuity/photographs alone.13
  • New ptosis with anisocoria is a red flag requiring immediate distinction between Horner syndrome (miotic pupil) and CN III palsy (mydriatic pupil, often with ophthalmoplegia) — the latter requires urgent neuroimaging if the pupil is involved.
  • Fatigability, variability through the day, or worsening with sustained upgaze should prompt myasthenia gravis workup, which by protocol should include chest imaging for thymoma screening in every confirmed case, not just those with additional systemic symptoms.2
  • Topical oxymetazoline has randomized-trial-level evidence for modest benefit in select acquired ptosis, offering a reasonable nonsurgical option before committing to surgical referral in appropriate mild cases.1

Common Pitfalls

  • Treating ptosis as purely cosmetic without assessing pupil size/reactivity and levator function, risking a missed compressive or neuromuscular diagnosis.
  • Assuming all nonsurgical options for acquired ptosis (oxymetazoline, adrenergic agents, botulinum toxin) have equivalent evidentiary support — the botulinum toxin approach specifically has more limited supporting data.1
  • Overlooking congenital myasthenic syndromes and other cranial neuropathies as distinct differentials from acquired myasthenia gravis when a child presents with variable ptosis.2
  • Failing to recognize surgical overcorrection (iatrogenic eyelid retraction) as a distinct, separately manageable complication rather than an unfixable outcome.4
  • Delaying pediatric ptosis referral when the lid is occluding the visual axis, given the amblyopia risk unique to the pediatric population.

References

  1. [1]Fathizadeh S, et al. Acquired Blepharoptosis for the Dermatologic Surgeon: Recognition, Assessment, and Nonsurgical Management. Dermatologic surgery. 2026.
  2. [2]Habib AA, Punga AR. Diagnosis of MG and differential diagnoses. International review of neurobiology. 2025.
  3. [3]Bhattacharjee K, et al. Journey of frontalis muscle advancement in severe blepharoptosis: Review of the techniques, modifications, and outcomes. Indian journal of ophthalmology. 2024.
  4. [4]Zhou X, et al. A Stepwise Management Strategy for Treatment of Iatrogenic Upper Eyelid Retraction in Eastern Asian Eyelids. Aesthetic plastic surgery. 2025.